Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: biosimilars - Polpharma Biologics

Next Previous
Drug Profile

Research programme: biosimilars - Polpharma Biologics

Alternative Names: BC 004; BC 006; BC 008; BC 009; BC 011; BC 012; BC 013; BC 014

Latest Information Update: 16 Jul 2020

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bioceros
  • Developer EPIRUS Biopharmaceuticals
  • Class Enzymes; Monoclonal antibodies; Recombinant fusion proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Unspecified

Most Recent Events

  • 13 Jul 2020 Polpharma Biologics acquired Bioceros and changed name to Polpharma Biologics
  • 28 Jul 2019 No recent reports of development identified for research development in Unspecified in Netherlands
  • 25 Jul 2016 EPIRUS Biopharmaceuticals files for Chapter 7 bankruptcy (Epirus Biopharmaceuticals 8-K, July 2016)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top